SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CTEC: Cholestech any other investors?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Duane L. Olson who wrote (474)4/1/1998 6:32:00 PM
From: Phil Rogers  Read Replies (2) of 710
 
This study, as it is being presented to the public - largely through the media, is a load of c--p. I say this as a cardiologist. The need, usefulness, and cost effectiveness of cholesterol screening has been demonstrated in many different patient populations. These studies have been among many thousands of patients. The usefulness of this devise remains very suspect. Thousands of studies get presented at the ACC meetings every March, and thousands more at the AHA meetings every November. There may be some usefulness for the study, but with its current capabilities, even those demonstrated with this machine used at St. Francis Hospital, the usefulness is very very limited. That doesn't mean it can't catch on. A lot of useless junk does.

Just one man's opinion (oh, and those of many of my colleagues)

Phil
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News